BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19712926)

  • 41. Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm.
    Cateau E; Berjeaud JM; Rodier MH; Imbert C
    Int J Antimicrob Agents; 2008 Feb; 31(2):166-70. PubMed ID: 18160264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth kinetics of candida biofilm on medical polymers: a long-term in vitro study.
    Leonhard M; Tobudic S; Moser D; Zatorska B; Bigenzahn W; Schneider-Stickler B
    Laryngoscope; 2013 Mar; 123(3):732-7. PubMed ID: 23070838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of serum and surface characteristics on Candida albicans biofilm formation.
    Frade JP; Arthington-Skaggs BA
    Mycoses; 2011 Jul; 54(4):e154-62. PubMed ID: 20337936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.
    Chandra J; McCormick TS; Imamura Y; Mukherjee PK; Ghannoum MA
    Infect Immun; 2007 May; 75(5):2612-20. PubMed ID: 17339351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.
    Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J
    Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of baicalein against Candida albicans biofilms.
    Cao Y; Dai B; Wang Y; Huang S; Xu Y; Cao Y; Gao P; Zhu Z; Jiang Y
    Int J Antimicrob Agents; 2008 Jul; 32(1):73-7. PubMed ID: 18374543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experiments on in vivo biofilm formation and in vitro adhesion of Candida species on polysiloxane liners.
    Mutluay MM; Oğuz S; Ørstavik D; Fløystrand F; Doğan A; Söderling E; Närhi T; Olsen I
    Gerodontology; 2010 Dec; 27(4):283-91. PubMed ID: 19804557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salivary pellicles equalise surfaces' charges and modulate the virulence of Candida albicans biofilm.
    Cavalcanti YW; Wilson M; Lewis M; Williams D; Senna PM; Del-Bel-Cury AA; da Silva WJ
    Arch Oral Biol; 2016 Jun; 66():129-40. PubMed ID: 26945171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed biofilms formed by C. albicans and non-albicans species: a study of microbial interactions.
    Santos JD; Piva E; Vilela SF; Jorge AO; Junqueira JC
    Braz Oral Res; 2016; 30():. PubMed ID: 26981754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The evaluation of relationship between the origin of Candida sp. and the ability of biofilm formation on surface of different biomaterials].
    Ciok-Pater E; Gospodarek E; Prazyńska M; Bogiel T
    Med Dosw Mikrobiol; 2009; 61(3):273-80. PubMed ID: 20120931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation.
    Bandara HMHN; Yau JYY; Watt RM; Jin LJ; Samaranayake LP
    J Med Microbiol; 2009 Dec; 58(Pt 12):1623-1631. PubMed ID: 19661208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms.
    Alnuaimi AD; O'Brien-Simpson NM; Reynolds EC; McCullough MJ
    FEMS Yeast Res; 2013 Nov; 13(7):689-99. PubMed ID: 23927631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioactivity and architecture of Candida albicans biofilms developed on poly(methyl methacrylate) resin surface.
    da Silva WJ; Seneviratne J; Samaranayake LP; Del Bel Cury AA
    J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):149-56. PubMed ID: 20524189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms.
    Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
    J Appl Microbiol; 2013 Apr; 114(4):1175-83. PubMed ID: 23231706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parylene coating hinders Candida albicans adhesion to silicone elastomers and denture bases resin.
    Zhou L; Tong Z; Wu G; Feng Z; Bai S; Dong Y; Ni L; Zhao Y
    Arch Oral Biol; 2010 Jun; 55(6):401-9. PubMed ID: 20400063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection.
    Pannanusorn S; Fernandez V; Römling U
    Mycoses; 2013 May; 56(3):264-72. PubMed ID: 23113805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secretory products of Escherichia coli biofilm modulate Candida biofilm formation and hyphal development.
    Bandara HM; Cheung BP; Watt RM; Jin LJ; Samaranayake LP
    J Investig Clin Dent; 2013 Aug; 4(3):186-99. PubMed ID: 23766273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Candida albicans biofilm formation on denture material.
    Redding S; Bhatt B; Rawls HR; Siegel G; Scott K; Lopez-Ribot J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):669-72. PubMed ID: 19426921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of extracellular DNA from Candida albicans and pneumonia-related pathogens on Candida biofilm formation and hyphal transformation.
    Sapaar B; Nur A; Hirota K; Yumoto H; Murakami K; Amoh T; Matsuo T; Ichikawa T; Miyake Y
    J Appl Microbiol; 2014 Jun; 116(6):1531-42. PubMed ID: 24661775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.